Pyrosequencing unveils cystic fibrosis lung microbiome differences associated with a severe lung function decline

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Bacci, Giovanni ^a   Paganin, Patrizia ^b   Lopez, Loredana ^c   Vanni, Chiara ^a   Dalmastri, Claudia ^b   Cantale, Cristina ^b   Daddiego, Loretta ^c   Perrotta, Gaetano ^c   Dolce, Daniela ^d   Morelli, Patrizia ^e   Tuccio, Vanessa ^f   De Alessandri, Alessandra ^e   Fiscarelli, Ersilia Vita ^f   Taccetti, Giovanni ^d   Lucidi, Vincenzina ^f   Bevivino, Annamaria ^a   Mengoni, Alessio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ENEA C R CASACCIA   (Italy)

^c Trisaia Research Center   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

16S RRNA GENE; ADULT; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; CHILD; COMMUNITY STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; DNA SEQUENCE; ECOLOGICAL NICHE; FEMALE; FORCED EXPIRATORY VOLUME; GENE TARGETING; GENETIC HETEROGENEITY; HOST PATHOGEN INTERACTION; HUMAN; LUNG FUNCTION; LUNG MICROBIOME; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; PATHOPHYSIOLOGY; POPULATION ABUNDANCE; POPULATION STRUCTURE; PREVOTELLA; PSEUDOMONAS; PYROSEQUENCING; SCHOOL CHILD; SEQUENCE ANALYSIS; SNEATHIA; SPECIES COMPOSITION; SPUTUM ANALYSIS; STAPHYLOCOCCUS; SUBSTANTIAL DECLINE; ADOLESCENT; CLINICAL TRIAL; ECOLOGY; GENETICS; ITALY; LUNG; LUNG FUNCTION TEST; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MULTICENTER STUDY; PHYLOGENY; RESPIRATORY FUNCTION; SPUTUM; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; ECOLOGY; FEMALE; HUMANS; ITALY; LUNG; MALE; MICROBIOTA; MIDDLE AGED; PHYLOGENY; PREVOTELLA; PSEUDOMONAS; RESPIRATORY FUNCTION TESTS; RESPIRATORY PHYSIOLOGICAL PHENOMENA; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SPUTUM; STAPHYLOCOCCUS; YOUNG ADULT;

EID: 84977537239     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156807     Document Type: Article

References (55)

1. Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, et al. European cystic fibrosis society standards of care: Best practice guidelines. J Cyst Fibros. 2014; 13. doi: 10.1016/j.jcf.2014.03.010
2. Sibley CD, Parkins MD, Rabin HR, Surette MG. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Curr Opin Investig Drugs. 2009; 10: 787-794. PMID: 19649923
3. Conrad D, Haynes M, Salamon P, Rainey PB, Youle M, Rohwer F. Cystic fibrosis therapy: a community ecology perspective. Am J Respir Cell Mol Biol. 2013; 48: 150-6. doi: 10.1165/rcmb.2012-0059PS PMID: 23103995
4. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010; 23: 299-323. doi: 10.1128/CMR.00068-09 PMID: 20375354
5. Lynch SV, Bruce KD. The cystic fibrosis airway microbiome. Cold Spring Harb Perspect Med. 2013; 3: a009738. doi: 10.1101/cshperspect.a009738 PMID: 23457293
6. Rogers GB, Shaw D, Marsh RL, Carroll MP, Serisier DJ, Bruce KD. Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax. 2014; 1-8. doi: 10.1136/thoraxjnl-2014-205826
7. Huang YJ, LiPuma JJ. The Microbiome in cystic fibrosis. Clin Chest Med. 2015; 37: 59-67. doi: 10.1016/j.ccm.2015.10.003 PMID: 26857768
8. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A. 2012; 109: 5809-14. doi: 10.1073/pnas.1120577109 PMID: 22451929
9. Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros. 2015; 14: 293-304. doi: 10.1016/j.jcf.2015.03.012 PMID: 25881770
10. Bittar F, Rolain J-M. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. Clin Microbiol Infect. 2010; 16: 809-20. doi: 10.1111/j.1469-0691.2010.03236.x PMID: 20880410
11. Delmont TO, Malandain C, Prestat E, Larose C, Monier J-M, Simonet P, et al. Metagenomic mining for microbiologists. ISME J. International Society for Microbial Ecology; 2011; 5: 1837-43. doi: 10.1038/ismej.2011.61
12. Rogers GB, Carroll MP, Hoffman LR, Walker AW, Fine DA, Bruce KD. Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes. 2010; 85-93. PMID: 21326915
13. Carmody LA, Zhao J, Schloss PD, Petrosino JF, Murray S, Young VB, et al. Changes in Cystic Fibrosis Airway Microbiota at Pulmonary Exacerbation. Ann Am Thorac Soc. American Thoracic Society; 2013; 10: 179-187. doi: 10.1513/AnnalsATS.201211-107OC
14. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, et al. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One. 2013; 8. doi: 10.1371/journal.pone.0062917
15. Filkins LM, O'Toole GA. Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS Pathog. 2015; 11: e1005258. doi: 10.1371/journal.ppat.1005258 PMID: 26719892
16. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A. 2008; 105: 15070-5. doi: 10.1073/pnas.0804326105 PMID: 18812504
17. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One. 2010; 5: e11044. doi: 10.1371/journal.pone.0011044 PMID: 20585638
18. Zhao J, Murray S, Lipuma JJ. Modeling the impact of antibiotic exposure on human microbiota. Sci Rep. 2014; 4: 4345. doi: 10.1038/srep04345 PMID: 24614401
19. VanDevanter DR, LiPuma JJ. Microbial diversity in the cystic fibrosis airways: where is thy sting? Future Microbiol. 2012; 7: 801-803. doi: 10.2217/fmb.12.55 PMID: 22827300
20. Paganin P, Fiscarelli EV, Tuccio V, Chiancianesi M, Bacci G, Morelli P, et al. Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function. PLoS One. 2015; 10: e0124348. doi: 10.1371/journal.pone.0124348 PMID: 25898134
21. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008; 153: S4-S14. doi: 10.1016/j.jpeds.2008.05.005 PMID: 18639722
22. Kerem E, Conway S, Elborn S, Heijerman H, Committee C, others. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005; 4: 7-26.
23. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994; 331: 637-42. doi: 10.1056/NEJM199409083311003 PMID: 7503821
24. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med. 1999; 340: 23-30. doi: 10.1056/NEJM199901073400104 PMID: 9878641
25. Flume PA, O'Sullivan BP, Robinson K a, Goss CH, Mogayzel PJ Jr, Willey-Courand DB, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007; 176: 957-969. doi: 10.1164/rccm.200705-664OC PMID: 17761616
26. Rogers GB, Skelton S, Serisier DJ, van der Gast CJ, Bruce KD. Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. J Clin Microbiol. 2010; 48: 78-86. doi: 10.1128/JCM.01324-09 PMID: 19906901
27. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009; 75: 7537-7541. doi: 10.1128/AEM.01541-09 PMID: 19801464
28. Bacci G, Bazzicalupo M, Benedetti A, Mengoni A. StreamingTrim 1.0: A Java software for dynamic trimming of 16S rRNA sequence data from metagenetic studies. Mol Ecol Resour. 2014; 14: 426-434. doi: 10.1111/1755-0998.12187 PMID: 24128146
29. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013; 10: 996-8. doi: 10.1038/nmeth.2604 PMID: 23955772
30. Konstantinidis KT, Tiedje JM. Prokaryotic taxonomy and phylogeny in the genomic era: advancements and challenges ahead. Current Opinion in Microbiology. 2007; 10: 504-509. doi: 10.1016/j.mib.2007.08.006 PMID: 17923431
31. Rogers GB, Cuthbertson L, Hoffman LR, Wing PAC, Pope C, Hooftman DAP, et al. Reducing bias in bacterial community analysis of lower respiratory infections. ISME J. International Society for Microbial Ecology; 2013; 7: 697-706. doi: 10.1038/ismej.2012.145
32. Eren AM, Borisy GG, Huse SM, Mark Welch JL. Oligotyping analysis of the human oral microbiome. Proc Natl Acad Sci U S A. 2014; 111: E2875-84. doi: 10.1073/pnas.1409644111 PMID: 24965363
33. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009; 10: 421. doi: 10.1186/1471-2105-10-421 PMID: 20003500
34. Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015; 67: 1-48. doi: 10.18637/jss.v067.i01
35. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/. R Found Stat Comput Vienna, Austria. 2012
36. Oksanen J, Blanchet F, Kindt R, Legendre P, Minchin P, O'Hara R, et al. Vegan: community ecology package. R package version 2.0-10. R package version. 2013. p. 10.4135/9781412971874.n145
37. Good IJ. The population frequencies of species and the estimation of population parameters. Biometrika. 1953; 40: 237-264. doi: 10.1093/biomet/40.3-4.237
38. Williams RJ, Howe A, Hofmockel KS. Demonstrating microbial co-occurrence pattern analyses within and between ecosystems. Front Microbiol. 2014; 5: 358. doi: 10.3389/fmicb.2014.00358 PMID: 25101065
39. Barberán A, Bates ST, Casamayor EO, Fierer N. Using network analysis to explore co-occurrence patterns in soil microbial communities. ISME J. 2012; 6: 343-51. doi: 10.1038/ismej.2011.119 PMID: 21900968
40. Fruchterman TMJ, Reingold EM. Graph drawing by force-directed placement. Softw Pract Exp. 1991; 21: 1129-1164. doi: 10.1002/spe.4380211102
41. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006; Complex Sy: 1695.
42. Faust K, Raes J. Microbial interactions: from networks to models. Nat Rev Microbiol. 2012; 10: 538-50. doi: 10.1038/nrmicro2832 PMID: 22796884
43. Mahenthiralingam E. Emerging cystic fibrosis pathogens and the microbiome. Paediatr Respir Rev. 2014; 15: 13-15. doi: 10.1016/j.prrv.2014.04.006
44. Surette MG. The cystic fibrosis lung microbiome. Ann Am Thorac Soc. 2014; 11: 61-65. doi: 10.1513/AnnalsATS.201306-159MG
45. Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F, editors. The Prokaryotes. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. doi: 10.1007/978-3-642-30197-1
46. Coenye T, Vanlaere E, Samyn E, Falsen E, Larsson P, Vandamme P. Advenella incenata gen. nov., sp. nov., a novel member of the Alcaligenaceae, isolated from various clinical samples. Int J Syst Evol Microbiol. 2005; 55: 251-256. doi: 10.1099/ijs.0.63267-0 PMID: 15653883
47. Jakobsen TH, Hansen MA, Jensen PØ, Hansen L, Riber L, Cockburn A, et al. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PLoS One. 2013; 8. doi: 10.1371/journal.pone.0068484
48. Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, Dowd SE, et al. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One. 2011; 6: e22702. doi: 10.1371/journal.pone.0022702 PMID: 21829484
49. Bittinger K, Charlson ES, Loy E, Shirley DJ, Haas AR, Laughlin A, et al. Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing. Genome Biol. 2014; 15: 487. doi: 10.1186/s13059-014-0487-y PMID: 25344286
50. Magalhães AP, Azevedo NF, Pereira MO, Lopes SP. The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy. Appl Microbiol Biotechnol. 2016; 100: 1163-81. doi: 10.1007/s00253-015-7177-x PMID: 26637419
51. Sam Ma Z, Guan Q, Ye C, Zhang C, Foster JA., Forney LJ. Network analysis suggests a potentially 'evil' alliance of opportunistic pathogens inhibited by a cooperative network in human milk bacterial communities. Sci Rep. 2015; 5: 8275. doi: 10.1038/srep08275 PMID: 25651890
52. Smith DJ, Badrick AC, Zakrzewski M, Krause L, Bell SC, Anderson GJ, et al. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. Eur Respir J. 2014; 44: 922-30. doi: 10.1183/09031936.00203013 PMID: 25034564
53. Shade A, Peter H, Allison SD, Baho DL, Berga M, Bürgmann H, et al. Fundamentals of microbial community resistance and resilience. Front Microbiol. 2012; 3: 417. doi: 10.3389/fmicb.2012.00417 PMID: 23267351
54. Wang Y, Zhang R, Zheng Q, Deng Y, Van Nostrand JD, Zhou J, et al. Bacterioplankton community resilience to ocean acidification: evidence from microbial network analysis. ICES J Mar Sci. 2016; 73: 865-875. doi: 10.1093/icesjms/fsv187
55. Duran-Pinedo AE, Paster B, Teles R, Frias-Lopez J. Correlation network analysis applied to complex biofilm communities. PLoS One. 2011; 6: e28438. doi: 10.1371/journal.pone.0028438 PMID: 22163302